Zenith Flex G48462Recalls & reported problems
Cook Incorporated · Zenith Flex, AAA Endovascular Graft Iliac Leg · Class 3 · Implant
All models of Zenith Flex (54)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10827002484624), received between Sep 23, 2019 and Sep 23, 2019 — classified as 1 injury.
The most frequently reported specific device problem is “Material Puncture/Hole” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Material Puncture/Hole1
Patient problems
- No Code Available1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjurySep 23, 2019Material Puncture/Hole; Material Puncture/Hole
IT WAS REPORTED THAT AFTER AN ENDOVASCULAR AORTIC REPAIR PROCEDURE, A HOLE IN A ZENITH FLEX AAA ENDOVASCULAR GRAFT ILIAC LEG WAS DISCOVERED UPON EXPLANT. THE DEVICE HAD BEEN PREVIOUSLY IMPLANTED IN AN (B)(6) MALE PATIENT WITH A PRE-EXISTING ABDOMINAL AORTIC ANEURYSM ON (B)(6) 2011. AFTER THE ENDOGRAFT WAS PLACED, THE ANEURYSM SAC REPORTEDLY CONTINUED TO GROW, WHICH LEAD TO THE NEED FOR AN ADDITIONAL PROCEDURE. COIL EMBOLIZATION OF THE INFERIOR MESENTERIC ARTERY WAS PERFORMED IN (B)(6) 2013. FOLLOWING IN (B)(6) 2015, A DIRECT SAC PUNCTURE WAS PERFORMED WITH GLUE EMBOLIZATION. IN (B)(6) 2018, A TYPE II EMBOLIZATION WAS UNSUCCESSFULLY ATTEMPTED. THERE WAS NO EVIDENCE OF A TYPE I OR TYPE III ENDOLEAK AT THAT TIME. THE DEVICE WAS ULTIMATELY EXPLANTED VIA THE ABDOMEN ON (B)(6) 2019, IN WHICH A HOLE IN THE GRAFT WAS REVEALED. THIS PROCEDURE WAS ACCOMPANIED BY AN OPEN ANEURYSM REPAIR. IT WAS REPORTED THAT BALLOONING WAS DONE AT THE TOP SEALING STENT OF THE TFFB, AS WELL AS THE FULL LENGTH OF THE LIMBS, INCLUDING THE OVERLAP. NO PORTION OF THE DEVICE REMAINED INSIDE OF THE PATIENT. NO ADDITIONAL ADVERSE EFFECTS HAVE BEEN REPORTED AT THE TIME OF THIS REPORT. IMAGING WILL BE PROVIDED TO THE M
Patient problems: No Code Available
MAUDE report 9105154 ↗
Other SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page